S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
TSE:CARE

Dialogue Health Technologies (CARE) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
C$5.12
C$5.14
52-Week Range
N/A
Volume
50,745 shs
Average Volume
58,690 shs
Market Capitalization
C$345.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$5.15

Dialogue Health Technologies MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
∞ Upside
C$5.15 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.17mentions of Dialogue Health Technologies in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.29 out of 5 stars

CARE stock logo

About Dialogue Health Technologies Stock (TSE:CARE)

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance program. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.

CARE Stock News Headlines

It’s Healthcare’s Data Era—Finally
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Towards health for all: Global experiences
Transcript: Women’s Heart Health
See More Headlines
Receive CARE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dialogue Health Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
240
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$5.15
High Stock Price Target
C$5.15
Low Stock Price Target
C$5.15
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
C$-19,500,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$95.88 million
Book Value
C$1.36 per share

Miscellaneous

Free Float
N/A
Market Cap
C$345.36 million
Optionable
Not Optionable
Beta
2.66
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Cherif Habib (Age 41)
    Co-Founder, CEO & Director
    Comp: $600k
  • Mr. Alexis Smirnov (Age 52)
    Co-Founder & CTO
    Comp: $437.5k
  • Mr. Navaid Mansuri (Age 50)
    Chief Financial Officer
    Comp: $481.25k
  • Mr. Jean-Nicolas Guillemette (Age 40)
    Chief Operating Officer
    Comp: $481.25k
  • Jennifer Buckley
    Sr. Vice-Pres of Commercial
  • Mr. Jean-Marc Ayas
    Director of Investor Relations
  • Melissa Azuelos
    Gen. Counsel
  • Jean-Christophe de Le Rue
    Director of Public & Gov. Relations
  • Lilian Lau
    VP of Marketing
  • Randy Wetmore
    VP of Sales

CARE Stock Analysis - Frequently Asked Questions

What is Dialogue Health Technologies' stock price target for 2024?

0 analysts have issued 12-month price objectives for Dialogue Health Technologies' stock. Their CARE share price targets range from C$5.15 to C$5.15. On average, they anticipate the company's stock price to reach C$5.15 in the next twelve months.
View analysts price targets for CARE
or view top-rated stocks among Wall Street analysts.

How do I buy shares of Dialogue Health Technologies?

Shares of CARE stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:CARE) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners